COMMUNITY HEALTHCARE TRUST I (CHCT)
US20369C1062 - REIT
Overall CHCT gets a fundamental rating of 4 out of 10. We evaluated CHCT against 126 industry peers in the Diversified REITs industry. CHCT has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHCT is quite expensive at the moment. It does show a decent growth rate. Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT was profitable.
In the past year CHCT had a positive cash flow from operations.
Each year in the past 5 years CHCT has been profitable.
CHCT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.54%, CHCT perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
CHCT has a Return On Equity (0.99%) which is comparable to the rest of the industry.
CHCT has a Return On Invested Capital of 2.13%. This is in the lower half of the industry: CHCT underperforms 60.98% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHCT is in line with the industry average of 2.95%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.54% | ||
| ROE | 0.99% | ||
| ROIC | 2.13% |
ROA(3y)1.8%
ROA(5y)1.84%
ROE(3y)3.07%
ROE(5y)3.04%
ROIC(3y)2.91%
ROIC(5y)2.96%
1.3 Margins
The Profit Margin of CHCT (4.52%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CHCT has declined.
The Operating Margin of CHCT (22.24%) is comparable to the rest of the industry.
CHCT's Operating Margin has declined in the last couple of years.
CHCT's Gross Margin of 81.63% is amongst the best of the industry. CHCT outperforms 80.49% of its industry peers.
CHCT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.24% | ||
| PM (TTM) | 4.52% | ||
| GM | 81.63% |
OM growth 3Y-15.52%
OM growth 5Y-4.28%
PM growth 3Y-41.7%
PM growth 5Y-8.07%
GM growth 3Y-0.15%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHCT is destroying value.
Compared to 1 year ago, CHCT has more shares outstanding
The number of shares outstanding for CHCT has been increased compared to 5 years ago.
Compared to 1 year ago, CHCT has a worse debt to assets ratio.
2.2 Solvency
CHCT has an Altman-Z score of 1.30. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CHCT (1.30) is better than 84.55% of its industry peers.
CHCT has a Debt/Equity ratio of 0.79. This is a neutral value indicating CHCT is somewhat dependend on debt financing.
CHCT has a better Debt to Equity ratio (0.79) than 71.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.3 |
ROIC/WACC0.29
WACC7.49%
2.3 Liquidity
CHCT has a Current Ratio of 0.66. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.66, CHCT is doing worse than 74.80% of the companies in the same industry.
CHCT has a Quick Ratio of 0.66. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT has a Quick ratio of 0.21. This is amonst the worse of the industry: CHCT underperforms 95.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.66 | ||
| Quick Ratio | 0.21 |
3. Growth
3.1 Past
The earnings per share for CHCT have decreased strongly by -78.05% in the last year.
The Earnings Per Share has been growing slightly by 1.25% on average over the past years.
Looking at the last year, CHCT shows a quite strong growth in Revenue. The Revenue has grown by 15.53% in the last year.
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 18.37% on average per year.
EPS 1Y (TTM)-78.05%
EPS 3Y-39.18%
EPS 5Y1.25%
EPS growth Q2Q-21.05%
Revenue 1Y (TTM)15.53%
Revenue growth 3Y14.24%
Revenue growth 5Y18.37%
Revenue growth Q2Q14.93%
3.2 Future
CHCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.28% yearly.
Based on estimates for the next years, CHCT will show a quite strong growth in Revenue. The Revenue will grow by 13.51% on average per year.
EPS Next Y342%
EPS Next 2Y125.83%
EPS Next 3Y78.28%
EPS Next 5YN/A
Revenue Next Year9.37%
Revenue Next 2Y9.42%
Revenue Next 3Y11.36%
Revenue Next 5Y13.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 141.72, CHCT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CHCT is valued a bit more expensive than 60.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHCT to the average of the S&P500 Index (24.76), we can say CHCT is valued expensively.
The Price/Forward Earnings ratio is 32.06, which means the current valuation is very expensive for CHCT.
CHCT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 73.98% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, CHCT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 141.72 | ||
| Fwd PE | 32.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHCT is valued a bit more expensive than the industry average as 68.29% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.98 |
4.3 Compensation for Growth
CHCT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 78.28% in the coming years.
PEG (NY)0.41
PEG (5Y)113.43
EPS Next 2Y125.83%
EPS Next 3Y78.28%
5. Dividend
5.1 Amount
CHCT has a Yearly Dividend Yield of 7.21%, which is a nice return.
CHCT's Dividend Yield is a higher than the industry average which is at 5.97.
Compared to an average S&P500 Dividend Yield of 2.40, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.21% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.33%.
CHCT has paid a dividend for at least 10 years, which is a reliable track record.
CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.33%
Div Incr Years8
Div Non Decr Years8
5.3 Sustainability
941.78% of the earnings are spent on dividend by CHCT. This is not a sustainable payout ratio.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP941.78%
EPS Next 2Y125.83%
EPS Next 3Y78.28%
COMMUNITY HEALTHCARE TRUST I
NYSE:CHCT (4/19/2024, 7:04:00 PM)
After market: 25.51 0 (0%)25.51
+0.33 (+1.31%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap706.37M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.21% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 141.72 | ||
| Fwd PE | 32.06 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.41
PEG (5Y)113.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.54% | ||
| ROE | 0.99% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 22.24% | ||
| PM (TTM) | 4.52% | ||
| GM | 81.63% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.66 | ||
| Quick Ratio | 0.21 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-78.05%
EPS 3Y-39.18%
EPS 5Y
EPS growth Q2Q
EPS Next Y342%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.53%
Revenue growth 3Y14.24%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y